MedPage Today) — NEW ORLEANS — Microaxial flow pump circulatory support with the Impella device during percutaneous coronary intervention (PCI) didn’t help outcomes for complex patients not in cardiogenic shock, two randomized trials at the…
News
🛡️ Just a quick check We’re checking your connection to prevent automated abuse
MedPage Today) — NEW ORLEANS — This weekend, catheter-based therapies have potentially practice-changing trial results expected at the American College of Cardiology (ACC) annual conference. Kicking off the opening late-breaking clinical…
Researchers at the University of California, Irvine, have developed a polymeric biohybrid cardiac device that harnesses the power of light to electrically and mechanically control living heart tissue without the use of metal electrodes. The innovation represents a leap forward in how scientists study heart disease…
🛡️ Just a quick check We’re checking your connection to prevent automated abuse
MedPage Today) — The concept of transesophageal echocardiography (TEE) guidance during CPR hit a wall when tested for the first time in a randomized trial. For patients who were in a prolonged out-of-hospital cardiac arrest (OHCA) and very sick…
MedPage Today) — An intervention designed to promote high fluid intake failed to reduce symptomatic stone recurrence in patients with a history of urinary stone disease, a randomized trial showed. Among over 1,600 participants, symptomatic stone…
El ensayo SPRINT encontrĂł que un tratamiento intensivo para reducir la presiĂłn sistĂłlica por debajo de 120 disminuĂa el riesgo de ataques cardĂacos, accidentes cerebrovasculares, otras enfermedades cardiovasculares y la mortalidad general…
For decades, language barriers have hindered researchers’ ability to assess child-caregiver relationships in refugee populations—an important component in designing and implementing interventions that promote the healthy development of displaced children. But a recent study led by Yale’s Qusai Khraisha validates a novel observational tool that allows researchers to accurately measure the quality of interactions between
MedPage Today) — Risk calculations guiding lipid-lowering therapy are given an overhaul in new guidelines from the American College of Cardiology (ACC) and American Heart Association (AHA). Now, in adults 30-79 years old without atherosclerotic…